Advertisement
Advertisement

CDXS

CDXS logo

Codexis, Inc.

2.25
USD
Sponsored
-0.02
-0.66%
Jun 25, 15:33 UTC -4
Open

CDXS Earnings Reports

Positive Surprise Ratio

CDXS beat 27 of 42 last estimates.

64%

Next Report

Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
$14.64M
/
-$0.14
Implied change from Q1 26 (Revenue/ EPS)
-4.02%
/
+40.00%
Implied change from Q2 25 (Revenue/ EPS)
-4.52%
/
-12.50%

Codexis, Inc. earnings per share and revenue

On May 07, 2026, CDXS reported earnings of -0.10 USD per share (EPS) for Q1 26, beating the estimate of -0.13 USD, resulting in a 28.26% surprise. Revenue reached 15.25 million, compared to an expected 14.82 million, with a 2.92% difference. The market reacted with a +10.47% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 7 analysts forecast an EPS of -0.14 USD, with revenue projected to reach 14.64 million USD, implying an increase of 40.00% EPS, and decrease of -4.02% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Codexis, Inc. reported EPS of -$0.10, beating estimates by 28.26%, and revenue of $15.25M, 2.92% above expectations.
The stock price moved up 10.47%, changed from $2.58 before the earnings release to $2.85 the day after.
The next earning report is scheduled for Aug 11, 2026.
Based on 7 analysts, Codexis, Inc. is expected to report EPS of -$0.14 and revenue of $14.64M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement